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The Salmonella enterica serotype Typhimurium genome contains 13 operons with homology to fimbrial gene
sequences. Here we investigated the role of 11 serotype Typhimurium fimbrial proteins, including FimA, AgfA
(CsgA), BcfA, StbA, SthA, LpfA, PefA, StdA, StcA, StiA, and StfA, as antigens during the infection of genetically
resistant mice (CBA). Upon the growth of serotype Typhimurium in standard laboratory broth culture, only the
expression of FimA could be detected by Western blot analysis. The infection of mice with serotype Typhi-
murium grown in broth culture, followed by at least one subsequent infection, resulted in seroconversion of
animals to FimA, AgfA, BcfA, StbA, SthA, LpfA, PefA, StdA, StcA, StiA, and StfA positivity. Most animals
seroconverted to only a subset of these fimbrial antigens. The immunization of mice with glutathione S-
transferase (GST)-FimA, GST-AgfA, GST-BcfA, GST-StbA, GST-SthA, GST-LpfA, GST-PefA, GST-StdA,
GST-StcA, GST-StiA, and GST-StfA fusion proteins resulted in reduced fecal shedding of serotype Typhi-
murium during a challenge compared to that by a control group immunized with purified GST protein.
Collectively, these data suggest that the expression of serotype Typhimurium fimbrial antigens is induced
during the infection of mice.
Salmonella serotypes are the leading cause of food-borne
infections with a lethal outcome in the United States (18).
Salmonella enterica serotype Typhimurium is the organism
most frequently associated with Salmonella-induced diarrhea
in humans (22). The intestinal carriage of Salmonella serotypes
by apparently healthy animals arriving at slaughter is respon-
sible for the introduction of the pathogen into the derived food
products (5, 7, 16, 24, 29). Fecal contamination of the environ-
ment is an important factor in the transmission of Salmonella
serotypes among farm animals (13, 17, 31, 32). Although the
presence of Salmonella serotypes in the intestines and feces of
farm animals is of importance for food safety, the underlying
mechanisms are poorly understood.
Fimbrial adhesins are potential candidates for mediating
attachment to intestinal surfaces (12). Whole-genome se-
quencing has revealed the presence of 13 operons containing
open reading frames with homology to fimbrial gene sequences
in the serotype Typhimurium genome (15). Only two of these
operons, fim and agf (csg), have been shown by electron mi-
croscopy to mediate the expression of fimbrial filaments on the
surfaces of serotype Typhimurium cells grown in broth or on
agar plates, respectively (6, 10). An expression analysis of pu-
tative major fimbrial subunits from 11 serotype Typhimurium
fimbrial operons by flow cytometry showed that only FimA is
detectable on the bacterial surface after growth of the organ-
ism in Luria-Bertani (LB) broth (11). However, the expression
of nine fimbrial operons was detected by flow cytometry on the
surfaces of serotype Typhimurium cells recovered 8 h after
infection from bovine ligated ileal loops (11). These data sug-
gest that the majority of serotype Typhimurium fimbrial anti-
gens are poorly expressed in vitro, while their expression is
induced in the host environment.
Each fimbrial filament on the bacterial surface is composed
of approximately 500 to 3,000 copies of a major fimbrial sub-
unit protein. The presence of large numbers of major fimbrial
subunits on the bacterial cell surface suggests that these anti-
gens may represent good targets for the host immune response.
To further investigate whether putative fimbrial operons iden-
tified by whole-genome sequencing are expressed in vivo, we
studied the role of 11 putative major subunit proteins as anti-
gens during serotype Typhimurium infections of mice.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Serotype Typhimurium strain AJB3,
a nalidixic acid-resistant derivative of serotype Typhimurium wild-type strain
SR11 (25), has been described previously (2). Escherichia coli strain DH5 has
been described previously (8). E. coli strain BL21(DE3) Star was obtained from
Invitrogen. Unless stated otherwise, strains were cultured either aerobically or
statically at 37°C in LB broth (10 g/liter tryptone, 5 g/liter yeast extract, 5 g/liter
NaCl). LB-pH 5.1 broth was prepared as described previously by buffering LB
broth with 100 mM 2-(N-morpholino)ethanesulfonic acid (MES) and adjusting
the pH to 5.1 with acetic acid (19). LB-NaCl broth contained 10 g/liter tryptone,
5 g/liter yeast extract, and 300 mM NaCl. Colonization factor antigen (CFA)
broth contained 1% Casamino Acids (Difco), 0.15% yeast extract (Difco),
0.005% MgSO4, 0.0005% MnCl2, 12 mM Na2HPO4, and 5 mM KH2PO4 (4).
Brain heart infusion (BHI) broth contained calf brain infusion (12.5 g/liter), beef
heart infusion (5 g/liter), proteose peptone (10 g/liter), NaCl (5 g/liter), glucose
(2 g/liter), and Na2HPO4 (2.5 g/liter). LB agar plates contained 15 g/liter agar
(Difco). If appropriate, antibiotics were added at the following concentrations:
carbenicillin, 100 mg/liter; chloramphenicol, 30 mg/liter; kanamycin, 60 mg/liter;
or nalidixic acid, 50 mg/liter.
His-tag fusion protein construction, expression, and purification. Plasmids
pSW5-50, pAH96, pAH99, pAH100, pAH97, pAH101, pAH103, pAH109,
pAH102, pAH107, and pAH111, encoding glutathione S-transferase (GST) fu-
sion proteins with serotype Typhimurium major fimbrial subunits (AgfA, BcfA,
StbA, SthA, LpfA, FimA, PefA, StdA, StcA, StiA, and StfA, respectively), were
described previously (11). The purification of GST fusion proteins was per-
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formed as described previously (11). An antiserum against each fusion protein
raised in rabbits has been described previously (11). Amino-terminal six-histi-
dine-tagged major fimbrial subunit fusion proteins were constructed by cloning
the BamHI/SmaI fragments from pAH96, pAH99, pAH100, pAH97, and
pAH111 into pQE30 (QIAGEN), giving rise to plasmids pSR1 (His-BcfA), pSR3
(His-StbA), pSR4 (His-SthA), pSR6 (His-LpfA), and pSR9 (His-StfA), respec-
tively. The BamHI/SalI fragment from pAH103 was cloned into pQE30, giving
pSR7 (His-PefA). Primers stdA1histag and stdA2histag (Table 1) were used to
amplify a region of the stdA gene corresponding to the major subunit without the
amino-terminal signal sequence, which was cloned into pCR2.1 TOPO (Invitro-
gen), giving pSR100-1. A BamHII/SmaI fragment of pSR100-1 was cloned into
pQE30, giving pSR11 (His-StdA). Carboxy-terminal histidine-tagged major fim-
brial subunit fusion proteins were constructed by amplifying fimA, stiA, stcA, and
agfA with the primers pET-FimA-1 and -2, pET-StiA-1 and -2, pET-StcA-1 and
-2, and AgfA-HisF and -R, respectively (Table 1). PCR products were cloned
directly into the pET101/D-TOPO directional cloning vector (Invitrogen), giving
pAH128 (FimA-His), pAH122 (StcA-His), pAH123 (StiA-His), and pAH132-13
(AgfA-His), respectively. E. coli DH5 was transformed with pSR1, pSR3, pSR4,
pSR6, pSR7, pSR9, or pSR11 (Table 2). BL21(DE3) Star (Invitrogen) was
transformed with pAH122, pAH123, pAH128, or pAH132-13 (Table 2). Log-
phase cultures of these transformants were induced to express the six-His-tagged
fusion proteins with the addition of 1 mM isopropyl--D-thiogalactopyranoside
(IPTG; Sigma) at 37°C (pAH132-13 was induced at 30°C to increase protein
solubility). The six-His-tagged fusion proteins encoded by plasmids pSR4, pSR6,
pSR7, pSR9, pAH122, pAH123, and pAH128 were purified with a HisTrap kit
(Amersham Pharmacia) under native conditions per the manufacturer’s proto-
col. The fusion proteins encoded by plasmids pSR1, pSR3, pSR11, and
pAH132-13 were purified under denaturing conditions according to instructions
by the manufacturer using Ni-nitrilotriacetic acid (Ni-NTA) agarose (QIAGEN).
Animal experiments. Throughout this study, 8- to 10-week-old female BALB/c
mice or 6- to 8-week-old female CBA/J mice were used (Jackson Laboratory).
To study seroconversion, fecal and blood samples were collected from naı¨ve
CBA/J mice prior to infection. A group of six mice was infected with serotype
Typhimurium (AJB3) grown to stationary phase in static LB broth at 37°C by
oral gavage with 2  109 CFU/animal. On days 16 and 33 after infection, mice
were given a dose of 3.8  109 CFU/animal by oral gavage. Fecal samples were
collected on day 45 after initial infection. Blood samples were collected into
heparinized capillary tubes (VWR) from the lateral saphenous vein punctured
with a 22G1 needle (Becton-Dickinson) on day 45 after initial infection. In a
second experiment, a group of three mice was inoculated with serotype Typhi-
murium on days 0, 14, and 73 with doses of 3  109, 3.9  109, and 2 
109CFU/animal, respectively, as described above. Blood and fecal samples were
collected 10 and 14 days after the first and second challenges and 17 days after
the final challenge. All blood samples were centrifuged at room temperature for
5 min at 8,000 rpm, and sera were removed, diluted 1:5 in phosphate-buffered
saline (PBS) plus 0.1% NaN3, and stored at 80°C. All fecal samples were
treated as described previously (28). Briefly, samples were frozen at 80°C
immediately after collection. Upon use, they were thawed on ice and resus-
pended in 1 ml PBS, pH 7.4, plus 0.1% NaN3 plus 50 l protease inhibitor
(Calbiochem) per 100 mg feces. Samples were vortexed and then dispersed by
microtip sonication at 50% duty for six 10-second bursts on ice, and particulate
matter was pelleted at 4,300 rpm for 5 min at 4°C. Supernatants were removed
and stored at 80°C until further use.
To study the effect of vaccination with fimbrial proteins on intestinal coloni-
zation, groups of CBA/J mice were immunized intraperitoneally with 0.1 ml of a
1:1 emulsion of either purified GST (control group; n  11), GST-BcfA (n  5),
GST-StdA (n  5), or GST-major fimbrial subunit proteins (fimbrial cocktail
group; n  17) and Titer-Max Gold (Sigma) as described below. On day 1, the
fimbrial cocktail group received 2 to 8 g/animal of GST-AgfA, GST-BcfA,
GST-LpfA, GST-PefA, and GST-StdA. On day 15, each mouse in the fimbrial
cocktail group received 4 to 10 g of GST-FimA, GST-StbA, GST-StcA, GST-
StfA, GST-SthA, and GST-StiA. On day 29, mice in the fimbrial cocktail group
received a booster immunization containing the first set of proteins, and 14 days
later, each animal received 5 to 10 g of the second group of GST-fimbrial fusion
proteins. The other groups were vaccinated on the same days with 20 g of GST,
GST-BcfA, or GST-StdA per mouse. Sera from mice in all four groups were
collected on day 54 and used in a Western blot against GST and the six-histidine-
tagged fimbrial fusion proteins at a 1:500 dilution to determine if serum immu-
noglobulin (Ig) antibodies had been raised against fimbrial major subunits or
GST. The fimbrial cocktail group received a booster immunization on day 69 that
contained 13.5 g/animal of GST-AgfA, 12 g/animal of GST-FimA, and 14
g/animal of GST-StiA. Serum samples from the fimbrial cocktail mice were
collected on day 85 and were analyzed for responses to FimA, StiA, and AgfA by
enzyme-linked immunosorbent assays (ELISAs). On day 98, the groups were
inoculated by oral gavage with 1  109 CFU of serotype Typhimurium AJB3
grown statically overnight at 37°C. Fecal samples from each mouse were col-
lected at the indicated time points, homogenized in 1 ml PBS, and plated on LB
plates containing nalidixic acid. On day 28 after serotype Typhimurium infection,
the cecum, Peyer’s patches, spleen, liver, mesenteric lymph nodes, and gall
bladder were collected and homogenized in PBS. Dilutions of homogenized fecal
and organ samples were plated on LB plates containing nalidixic acid. All data
were converted logarithmically prior to the calculation of averages and statistical
analysis. Student’s t test was used to determine whether the average log CFU/mg
feces for the control group was significantly different from that for the fimbrial
cocktail-immunized group on each day postchallenge. P values of 0.05 were
considered significant.
To look at fimbrial expression in the ceca of mice infected with serotype
Typhimurium, 8- to 10-week-old female BALB/c mice (n  3; see Table 5) were
inoculated with approximately 1  109 CFU of serotype Typhimurium strain
SR11. After 6 days, the cecum was collected from each mouse and fixed in 10%
formalin. Tissues were embedded in paraffin, and 0.5-m sections were prepared
for immunofluorescence microscopy.
TABLE 1. Oligonucleotide primers used to construct plasmids encoding six-histidine-tagged fusion proteins
Primer Sequence (5	-3	) Plasmid with fragmentin pET101-D/TOPO
Plasmid with fragment
in pQE30
agfA-HisF CACCATGAAACTTTTAAAAGTGGCAG pAH132-13
agfA-HisR ATACTGGTTAGCCGTGGCGTTG
pETFimA1 CACCATGTCGATAATAATTCAAACG pAH128-1
pETFimA2 TTCGTATTTCATGATAAAGGTG
stdA1 (histag) CGCGGATCCGCCGATACTACACCCACAGC pSR11
stdA2(histag) TCCCCCGGGCGACTTCAGGACGGAAAATGTC
pETStcA1 CACCATGAAACGTTCACTTATTGC pAH122
pETStcA2 AGTAACAACCGTTAAAGTCAGT
pETStiA1 CACCATGAAACTCTCCTTAAA pAH123
pETStiA2 ATATTGCAGATAGAATGTTGCGG
TABLE 2. Plasmids encoding six-histidine-tagged fusions to major
fimbrial subunits
Fusion protein Plasmid
His-BcfA.................................................................................pSR1
His-StbA.................................................................................pSR3
His-SthA.................................................................................pSR4
His-LpfA ................................................................................pSR6
His-StfA..................................................................................pSR9
His-PefA.................................................................................pSR7
His-StdA.................................................................................pSR11
FimA-His ...............................................................................pAH128
StcA-His .................................................................................pAH122
StiA-His..................................................................................pAH123
AgfA-His ................................................................................pAH132-13
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Immunofluorescence microscopy. Antisera specific for GST-BcfA, GST-LpfA,
and GST-StcA have been described previously (11). Anti-GST antibodies were
removed by preadsorbing each serum with E. coli DH5(pGEX 4T-2) using a
previously described protocol (9). A Salmonella O group B (factors 1, 4, 5, 12,
and 27) (Becton Dickinson)-specific antiserum was used to detect the O antigen
of serotype Typhimurium lipopolysaccharide (LPS). All antisera were filtered
(0.2-m pore size) and loaded on a recombinant protein G-agarose column
(Invitrogen) according to the manufacturer’s instructions. Purified antibodies
were eluted from the protein G column in 2 ml of 0.1 M glycine hydrochloride
(pH 2.6), and a pH of 7 was obtained by the addition of 1 M Tris-HCl, pH 8. The
antibodies were concentrated, and the glycine buffer was exchanged for PBS, pH
7.4, in Centricon centrifugal filter devices with a molecular mass cutoff of 10 kDa
(Millipore). These solutions (0.5 ml) were then labeled with either an Alexa
Fluor 594 protein labeling kit (for the Salmonella O group B antiserum) or an
Alexa Fluor 488 protein labeling kit (for the anti-GST-BcfA, anti-GST-LpfA,
and anti-GST-StcA antisera) according to the manufacturer’s instructions (Mo-
lecular Probes).
Sections of the ceca of BALB/c mice collected 6 days after infection with
serotype Typhimurium were deparaffinized by standard procedures (incubation
at 50°C for 20 min and three washes for 5 min each time in xylene, followed by
5-min washes in 95% ethanol, 70% ethanol, and distilled H2O). Sections were
then blocked in 5% nonfat dried milk plus 0.05% Tween 20 in PBS for 1 h. A 1:50
dilution of Alexa Fluor 594-labeled Salmonella O group B antiserum, a 1:50
dilution of Alexa Fluor 488-labeled antifimbrial antiserum (anti-GST-BcfA, anti-
GST-LpfA, or anti-GST-StcA), and a 1:1,000 dilution of Hoechst stain (0.5
mg/ml) were added in 1 ml of blocking buffer to each slide. Slides were incubated
for 1 h at room temperature in the dark before they were washed three times for
5 min each time in blocking buffer and three times for 5 min each time in PBS,
pH 7.4. Excess liquid was removed from around the tissues, and SlowFade
antifade solution (Molecular Probes) was applied to each slide before the cov-
erslip was added and sealed with clear polish. The slides were incubated in the
dark overnight at room temperature before analysis.
Western blot analysis. An analysis of serum samples by Western blotting was
performed by separating 0.5 g of affinity chromatography-purified GST (con-
trol) and 0.5 g of each affinity chromatography-purified His-tagged fusion
protein by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) on a 12% gel. After electrophoresis, the proteins were transferred to
Immobilon-P membranes (Millipore) using a Trans-Blot SD semidry electro-
phoretic transfer cell (Bio-Rad) according to the manufacturer’s instructions.
Blots were blocked in PBS containing 5% nonfat dry milk, 0.05% Tween 20, and
0.02% NaN3 (blocking buffer) at room temperature for 1 h or overnight at 4°C.
Each blot was incubated with a 1:500 dilution of serum or a 1:25 dilution of a
fecal preparation taken from a particular mouse either before or after the
challenge with serotype Typhimurium. All samples were diluted in blocking
buffer and incubated at room temperature for 2 to 3 h, with agitation. Blots were
washed three times for 5 min each time with blocking buffer. Blots detecting
serum IgG antibodies were transferred to a solution with a 1:20,000 dilution of
goat anti-mouse IgG (Fab specific)–alkaline phosphatase conjugate (Sigma) in
blocking buffer and were incubated at room temperature for 1 h with agitation.
Blots detecting fecal IgA antibodies were transferred to a solution with a
1:20,000 dilution of goat anti-mouse IgA–biotin (Amersham) in blocking buffer
for 1 h at room temperature, with agitation. These blots were then washed three
times for 5 min each time in blocking buffer and transferred to a 1:10,000 dilution
of streptavidin-peroxidase polymer conjugate (Sigma) in blocking buffer for 1 h
at room temperature, with agitation. All blots were then washed three times for
5 min each time with blocking buffer and three times with PBS. Signals were
generated using Immun-star substrate (Bio-Rad) or the ECL Plus detection
substrate (Amersham).
For a Western blot analysis of serotype Typhimurium grown overnight stati-
cally in LB broth, LB broth buffered to pH 5.1, LB-NaCl broth, BHI broth, or
CFA broth, cultures were harvested by centrifugation. Whole-cell lysates were
prepared by previously established protocols (4), including boiling in SDS-PAGE
sample buffer containing 0.2 M glycine-HCl (pH 1.5), 0.5% deoxycholate, 2%
SDS, or 5% -mercaptoethanol for 10 min following electrophoresis. Alterna-
tively, bacterial pellets were treated briefly with 90% formic acid and frozen, the
acid was removed with a Speed Vac concentrator for 1 h, and the pellets were
resuspended in SDS-PAGE sample buffer. Cells were boiled for 10 min and
analyzed by electrophoresis.
ELISA to detect antibodies to LPS. The detection of antibodies against sero-
type Typhimurium LPS was based on a previously described protocol (28). In
brief, LPS from serotype Typhimurium prepared by phenol extraction (Sigma)
was resuspended in coating buffer (0.1 M sodium carbonate, 1.0 M NaCl, pH
9.6), and 96-well Polysorb ELISA plates (Nunc) were coated with 5 g of antigen
per well and incubated overnight at 37°C. The plates were washed four times with
distilled water and patted dry before being blocked for 1 h at 37°C in blocking
buffer (PBS plus 1% Tween 20). The plates were washed as before, and mouse
serum (0.05 ml/well) was then added to the antigen-coated plates in duplicate
twofold serial dilutions with blocking buffer as the diluent and incubated on a
rocker overnight at 4°C. Plates were washed 10 times in washing buffer (PBS plus
0.05% Tween 20), and binding of the mouse serum was detected by using goat
anti-mouse IgG–alkaline phosphatase conjugate diluted 1:1,000 in blocking
buffer. Plates were incubated with secondary antibodies for 1 h at 37°C and
washed 10 times with washing buffer. Detection was performed with 0.05 ml of
p-nitrophenylphosphate (1 mg/ml; Sigma) diluted in glycine buffer (0.1 M gly-
cine, 1 mM MgCl2, 1 mM ZnCl2, pH 10.4). Plates were developed at 37°C for 1 h,
and the reaction was stopped by the addition of 0.05 ml of 0.5 M EDTA. The
alkaline phosphatase activity in each well was determined by measuring the
absorbance at 410 nm, and the highest serum dilution giving a reading above the
background level was determined. Antibody titers are reported as fold increases
in immune serum over naı¨ve serum.
HisSorb ELISA to detect seroconversion. Ni-NTA HisSorb ELISAs were
performed per the manufacturer’s instructions (QIAGEN). In brief, the satura-
tion conditions for binding to Ni-NTA-coated wells were determined for each
six-His-tagged fusion protein by applying increasing concentrations of protein to
the HisSorb plates and incubating them in PBS plus 0.2% bovine serum albumin
(BSA) with pH values ranging from 7.0 to 8.0 at 37°C or 4°C (Table 3). Subse-
quent binding studies were performed at saturation. To determine the concen-
tration of seroconversion antibodies to the fimbrial major subunits from a par-
ticular mouse, the fusion proteins were loaded onto the plates at the indicated
concentrations in a total volume of 0.2 ml of PBS plus 0.2% BSA, pH 7.5
(PBS-BSA), and allowed to incubate at either 37°C or with rocking at 4°C
overnight. The plates were then washed four times with PBS plus 0.05% Tween
20 (PBS-Tween) and dried. Naive or immune samples diluted in PBS-BSA were
then added to the wells and diluted in twofold serial dilutions. Plates were
allowed to incubate overnight at 4°C with agitation. After four washes with
PBS-Tween, 0.2 ml of a 1:10,000 dilution of secondary antibody (goat anti-mouse
IgG [Fab specific], goat anti-mouse IgG [
 chain specific], or goat anti-mouse
IgA [ chain specific], all conjugated to alkaline phosphatase) diluted in PBS-
BSA was added to all wells and incubated at room temperature with agitation for
2 h. After the plates were washed four times, 0.05 ml of 1-mg/ml p-nitrophe-
nylphosphate (Sigma) was added to each well, and the plates were incubated at
37°C for 1 h. The colorimetric reaction was stopped by adding 0.05 ml 0.5 M
EDTA to each well. The alkaline phosphatase activity in each well was deter-
mined by measuring the absorbance at 410 nm, and the highest serum dilution
giving a reading above the background level was determined. Antibody titers are
reported as fold increases in immune serum over naı¨ve serum.
ELISAs to detect serum antibody titers from vaccinated mice. HisSorb
ELISAs to determine the antibody titers of fimbrial cocktail- or GST-immunized
mice were performed basically as described above. ELISA plates were coated
with a six-His-tagged major fimbrial subunit fusion protein, and serum taken
from each mouse in the cocktail group was loaded in the plates in duplicate
twofold serial dilutions. The titers from these sera were compared to titers from
a pooled sample of sera from the control group (GST-immunized mice) loaded
in the same plate in duplicate twofold serial dilutions. Serum Ig titers were
detected with a 1:5,000 dilution of goat anti-mouse IgG (Fab specific)–alkaline
TABLE 3. Optimal binding conditions for each of the six-histidine-
tagged major fimbrial subunit proteins in Ni-NTA HisSorb ELISA
plates (Qiagen)
Plasmid with six-His-
tagged major subunit
Amt of protein
(g/well)
Binding temp
(°C) pH
pSR1 12 37 7.5
pAH128 8 4 7.5
pSR3 10 37 7.5
pSR4 10 4 7.5
pSR6 6 37 or 4 7.5
pSR7 13 37 7.5
pAH122 8 4 7.5
pSR9 12 4 7.5
pSR11 12 4 7.5
pAH123 11 4 7.5
pAH132-13 12 37 7.5
VOL. 73, 2005 S. ENTERICA FIMBRIAL ANTIGENS 5331
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
phosphatase conjugate (Sigma). The alkaline phosphatase activity in each well
was determined as described above. The absorbance at 410 nm for the serum at
a titer of 320 among the pooled samples from the control group was used as the
background cutoff absorbance for comparison to samples from the fimbrial
cocktail-immunized group. The first well with an absorbance above background
levels was considered positive. Each titer is reported as the fold increase over the
titer of the pooled control group samples.
RESULTS
In vitro expression of serotype Typhimurium fimbrial pro-
teins detected by Western blotting. We have recently shown
that a serotype Typhimurium wild-type strain (AJB3) grown to
stationary phase in static LB broth at 37°C expresses FimA on
its surface, while no surface expression of AgfA, BcfA, StbA,
SthA, LpfA, PefA, StdA, StcA, StiA, or StfA is detectable by
flow cytometry (11). To further investigate whether the expres-
sion of fimbrial subunits was detectable after in vitro growth in
broth, we performed a Western blot analysis with whole-cell
lysates of serotype Typhimurium using rabbit serum specific
for FimA, AgfA, BcfA, StbA, SthA, LpfA, PefA, StdA, StcA,
StiA, or StfA. Whole-cell lysates were prepared by three pro-
tocols that were previously described for the disassembly of
fimbriae (4). Static growth at 37°C of serotype Typhimurium
strain AJB3 in LB broth (pH 7) resulted in the expression of
FimA, while neither AgfA, BcfA, StbA, SthA, LpfA, PefA,
StdA, StcA, StiA, nor StfA was detectable by Western blotting
(data not shown).
An analysis of serotype Typhimurium grown in LB broth
buffered to pH 5.1 or in CFA broth by flow cytometry using
rabbit serum against AgfA, BcfA, StbA, SthA, LpfA, PefA,
StdA, StcA, StiA, or StfA and an anti-rabbit–fluorescein iso-
thiocyanate conjugate showed that in each case, none or only
a small fraction of cells (5%) showed fluorescence above
background levels (11). To determine whether the low level of
fimbrial expression in LB broth buffered to pH 5.1 or in CFA
broth can be detected by Western blotting, serotype Typhi-
murium cultures grown under these conditions were analyzed
as described above. The growth of serotype Typhimurium in
LB broth buffered to pH 5.1 or in CFA broth resulted in the
expression of FimA, while neither AgfA, BcfA, StbA, SthA,
LpfA, PefA, StdA, StcA, StiA, nor StfA was detectable by
Western blotting (data not shown). Similarly, FimA was the
only fimbrial protein detected by Western blotting in serotype
Typhimurium cultures grown in BHI broth or LB-NaCl broth
(data not shown).
Seroconversion to fimbrial proteins during serotype Typhi-
murium infection of mice detected by Western blotting. To
determine whether serotype Typhimurium fimbriae serve as
antigens in vivo, the immune response to the major fimbrial
subunits was analyzed after the infection of genetically resis-
tant mice (CBA/J mice) with serotype Typhimurium (AJB3)
grown to stationary phase in static LB broth at 37°C. Since the
bacterial culture used to inoculate mice only expressed FimA
(as shown by Western blotting and flow cytometry), we rea-
soned that seroconversion to other fimbrial proteins observed
during infection would provide indirect evidence of their in
vivo expression. Mice were inoculated with serotype Typhi-
murium strain AJB3 intragastrically on days 0, 16, and 33, and
serum and fecal samples were collected prior to infection and
on day 45 after infection.
To investigate seroconversion, we generated plasmids en-
coding six-histidine-tagged fusions with major fimbrial sub-
units, including His-BcfA, His-StbA, His-SthA, His-LpfA, His-
StfA, His-PefA, His-StdA, FimA-His, StcA-His, and StiA-His.
These fusion proteins were affinity chromatography purified
and separated by SDS-PAGE (Fig. 1). Serum and fecal sam-
ples were investigated for the presence of antibodies (serum Ig
or fecal IgA) directed against fimbriae by Western blotting
with the His-BcfA, His-StbA, His-SthA, His-LpfA, His-StfA,
His-PefA, His-StdA, FimA-His, StcA-His, and StiA-His fusion
proteins (Fig. 1 and Table 4).
Fecal samples from four mice collected prior to infection
and on day 45 after infection were analyzed by Western blot-
ting for the presence of fecal IgA recognizing fimbrial fusion
proteins. Fecal pellets collected on day 45 after infection con-
tained IgA antibodies to 1 (mouse no. 2), 7 (mouse no. 6), or
8 (mouse no. 1 and 3) of the 10 fusion proteins tested (Table
4). In contrast, no IgA antibodies recognizing fimbrial proteins
were detected in fecal pellets collected prior to infection. A
representative Western blot of a fecal IgA response is shown in
Fig. 1. Naı¨ve sera and sera collected on day 45 after infection
from five mice were investigated for antibodies against fimbrial
proteins. Sera collected on day 45 after infection contained Ig
against 1 (mouse no. 4 and 5), 2 (mouse no. 6), 3 (mouse no.
2), or 7 (mouse no. 3) of the 10 fusion proteins tested (Table
4). No antibodies recognizing fimbrial proteins were detected
in naı¨ve sera from the same animals. Collectively, these data
suggested that all major fimbrial subunits studied in this ex-
periment (i.e., BcfA, StbA, SthA, LpfA, StfA, PefA, StdA,
FimA, StcA, and StiA) served as antigens during the infection
FIG. 1. Detection of fecal IgA against fimbrial antigens by Western
blotting. (A) SDS-PAGE gel of purified His-tagged fusion proteins
stained with Coomassie blue. (B) Western blot of an SDS-PAGE gel
loaded with the same proteins as the gel in the top panel, detected with
IgA extracted from fecal samples collected from a naı¨ve mouse.
(C) Fecal samples from the same animal were collected on day 45 after
infection with serotype Typhimurium grown in static LB broth. The
panel shows a Western blot (loaded identically to the panels above)
detected with IgA extracted from a fecal sample collected 45 days after
infection. Lane 1, HisBcfA; lane 2, FimA-His; lane 3, His-StbA; lane 4,
His-SthA; lane 5, His-LpfA; lane 6, His-PefA; lane 7, StcA-His; lane 8,
His-StfA; lane 9, His-StdA; lane 10, StiA-His.
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of mice (Table 4). However, none of the serum or fecal sam-
ples from infected animals contained antibodies against all 10
fimbrial proteins investigated. Instead, each animal developed
serum Ig or fecal IgA responses to only a subset of these
fimbrial antigens.
To quantify the antibody responses to fimbrial proteins, we
analyzed serum Ig titers by ELISA. Three CBA mice were
infected with serotype Typhimurium and then challenged with
serotype Typhimurium 24 days and 73 days after the initial
infection. The His-BcfA, His-StbA, His-SthA, His-LpfA, His-
StfA, His-PefA, His-StdA, FimA-His, StcA-His, AgfA-His,
and StiA-His fusion proteins were adsorbed to Ni-NTA-coated
wells, and the serum Ig titers were determined using serial
twofold dilutions of naı¨ve sera and immune sera collected from
mice. As a control, we determined the Ig titers to purified
serotype Typhimurium LPS by ELISA. Titers against LPS con-
tinuously increased (naı¨ve titer  titer 10 days after infection
 titer 28 days after infection  titer 90 days after infection)
during the duration of the experiment. An eightfold or more
increase in anti-LPS Ig titers was observed in sera from all
animals collected 28 days after infection compared to naı¨ve
serum samples (Table 5). An eightfold or more increase in the
Ig titer in immune serum compared to that in naı¨ve serum was
detected for AgfA, BcfA, and StdA for mouse 7, for BcfA,
StcA, and SthA for mouse 8, and for BcfA, FimA, and PefA for
mouse 9. For two animals (mouse no. 7 and 8), antibody titers
against fimbrial proteins peaked at the last time point (90 days
after infection), while the greatest titers were obtained 28 days
after infection for the remaining animal (mouse no. 9) (Table
5). Generally, serum conversion to LPS (8-fold to 512-fold
increase in titer) was stronger than that observed to fimbrial
proteins.
Immunization of mice with multiple fimbrial antigens. To
investigate how an immune response against all of the fimbrial
antigens would affect intestinal colonization by serotype Ty-
phimurium, we immunized CBA mice either with a purified
GST protein (control group) or with a cocktail consisting of 11
GST fusions to fimbrial subunits (cocktail group). In a pilot
experiment in which CBA mice were given all 11 GST-fimbrial
fusion proteins, we noted that animals only developed an im-
mune response to a subset of these antigens, as assessed by
Western blotting (data not shown). The vaccination procedure
was thus modified, and animals in the cocktail group received
an injection of a mixture consisting of GST-AgfA, GST-BcfA,
GST-LpfA, GST-PefA, and GST-StdA, followed 15 days later
by an injection of a mixture consisting of GST-FimA, GST-
TABLE 4. Seroconversion to fimbrial antigens, as determined by Western blotting
Animal no. Response measured
Seroconversion () to fimbrial protein
BcfA FimA StbA SthA LpfA PefA StcA StfA StdA StiA
1 Fecal IgA          
2 Fecal IgA          
Serum Ig          
3 Fecal IgA          
Serum Ig          
4 Serum Ig          
5 Serum Ig          
6 Fecal IgA          
Serum Ig          
TABLE 5. Seroconversion to fimbrial antigens, as determined by ELISA
Antigen
Fold increase in immune serum titer over naı¨ve serum titer on indicated day p.i.a
Mouse 7 Mouse 8 Mouse 9
10 28 90 10 28 90 10 28 90
AgfA 3 10 8 ND ND 4 1 3 2
BcfA ND ND 8 ND ND 8 1 12 4
FimA ND ND 4 ND ND 2 1 16 8
LpfA ND ND 4 ND ND 2 1 5 3
PefA ND ND 2 ND ND 2 1 12 3
StbA ND ND 1 ND ND 1 1 5 2
StcA ND ND 4 3 10 20 1 3 1
StdA 3 5 8 ND ND 4 2 3 4
StfA ND ND 4 ND ND 2 2 6 4
SthA ND ND 4 3 5 10 1 4 2
StiA ND ND 4 ND ND 2 1 3 2
LPS 2 288 512 2 12 128 1 8 64
a ND, not determined.
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StbA, GST-StcA, GST-StfA, GST-SthA, and GST-StiA. This
vaccination was repeated, and fecal IgA and serum Ig were
collected 11 days after the last immunization. Antibodies to
fimbrial antigens were detected by Western blotting using the
His-BcfA, His-StbA, His-SthA, His-LpfA, His-StfA, His-PefA,
His-StdA, FimA-His, StcA-His, AgfA-His, and StiA-His fusion
proteins, while anti-GST antibodies were detected using puri-
fied GST. All mice in the control group had antibodies to GST
but not to fimbrial antigens, as determined by Western blots
using a 1:200 dilution of serum (Fig. 2). Mice in the cocktail
group had responses to BcfA, StbA, SthA, LpfA, StfA, PefA,
StdA, and StcA, but in most animals in the cocktail group,
responses to AgfA, FimA, and StiA were low or absent (Fig. 2).
The cocktail group thus received a final boost consisting of
GST-AgfA, GST-FimA, and GST-StiA. A final blood sample
was collected from animals 16 days after the last booster im-
munization.
To quantify the antibody responses to fimbrial proteins in
the cocktail group, we analyzed serum Ig titers from samples
collected after immunization for 10 mice from each group. The
His-BcfA, His-StbA, His-SthA, His-LpfA, His-StfA, His-PefA,
His-StdA, FimA-His, StcA-His, AgfA-His, and StiA-His fusion
proteins were adsorbed to Ni-NTA-coated wells, and the se-
rum Ig titers were determined by ELISA as described above.
The average increases in antibody titers in the cocktail group
compared to those in the control group are shown in Table 6.
The serum Ig response to FimA remained poor despite re-
peated immunizations. However, the responses to the other
fimbrial antigens were, on average, increased compared to
those in mice infected with serotype Typhimurium (Tables 5
and 6).
Twenty-nine days after the last immunization, both groups
of mice were challenged with serotype Typhimurium. Fecal
samples were collected over a 28-day period to determine the
number of bacteria shed with the feces. Mice in the cocktail
group shed significantly lower numbers (P  0.05) of serotype
Typhimurium with their feces than did mice in the control
group on days 5, 7, 9, 15, and 20 after infection (Fig. 3A). By
day 28, both groups were colonized by similar numbers of
bacteria. When bacteria were recovered from organs on day 28
after infection, there was also no difference in the colonization
FIG. 2. Response to fimbrial antigens after vaccination with GST (control group) or with a cocktail containing 11 GST-fimbrial fusion proteins
(cocktail group), as detected by Western blotting. Mice in the cocktail group received two injections with a mixture of GST-AgfA, GST-BcfA,
GST-LpfA, GST-PefA, and GST-StdA and two injections with a mixture of GST-FimA, GST-StbA, GST-StcA, GST-StfA, GST-SthA, and
GST-StiA. Mice in the control group received two injections with purified GST protein. The left panel shows Western blots of serum samples
collected after vaccination from four animals in the cocktail group. The right panel shows Western blots of serum samples collected after
vaccination from four animals in the control group. Lanes 1, HisBcfA; lanes 2, FimA-His; lanes 3, His-StbA; lanes 4, His-SthA; lanes 5, His-LpfA;
lanes 6, His-PefA; lanes 7, StcA-His; lanes 8, His-StfA; lanes 9, His-StdA; lanes 10, StiA-His; lanes 11, AgfA-His; lanes 12, GST.
TABLE 6. Titers of antibodies to fimbrial antigens elicited
by vaccination
Antigen
Average fold increase in serum Ig titer
for mice in cocktail group compared
to that for mice in control group
BcfAa............................................................................. 60
FimAb ........................................................................... 2
StbAa............................................................................. 5
SthAa............................................................................. 8
LpfAa ............................................................................ 26
PefAa............................................................................. 5
StcAa ............................................................................. 5
StfAa.............................................................................. 10
StdAa............................................................................. 53
StiAb.............................................................................. 5
AgfAb ............................................................................ 5
a Titers were measured in samples collected 54 days after the first vaccination
(i.e., after the second GST-FimA, GST-StbA, GST-StcA, GST-StfA, GST-SthA,
and GST-StiA injection).
b Titers were measured in samples collected 85 days after the first vaccination
(i.e., after the booster injection with GST-AgfA, GST-StiA, and GST-FimA).
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of the cecum (P 0.05) (Fig. 3B). However, the animals in the
control group carried higher numbers of bacteria in the spleen,
on average, than did animals in the cocktail group (P  0.05).
To determine whether immunization with those fimbrial an-
tigens that had elicited high antibody titers (i.e., BcfA and
StdA [Table 6]) would reduce fecal shedding when used indi-
vidually for vaccination, groups of five mice were immunized
with GST-BcfA, GST-StdA, or GST and subsequently chal-
lenged with serotype Typhimurium as described above. Mice in
the GST-BcfA and GST-StdA vaccine groups shed similar
numbers of serotype Typhimurium with their feces to those
shed by mice in the cocktail group (data not shown).
Detection of fimbrial expression in the murine cecum by
fluorescence microscopy. To directly analyze the in vivo ex-
pression of selected fimbrial antigens, BALB/c mice were in-
oculated with serotype Typhimurium, and ceca were collected
6 days after infection. Serotype Typhimurium was detected by
fluorescence microscopy with Alexa Fluor 594-labeled anti-O
antiserum (red fluorescence), and the expression of fimbrial
proteins (BcfA, StcA, and LpfA) was detected with Alexa
Fluor 488-labeled antiserum (green fluorescence). Colocaliza-
tion of red and green fluorescence provided further evidence
of the in vivo expression of BcfA, StcA, and LpfA in the ceca
of mice (Fig. 4).
DISCUSSION
The elaboration of type 1 fimbriae on the surfaces of sero-
type Typhimurium cells grown in broth culture was first de-
scribed by electron microscopic observation in 1958 (6). The
biosynthesis of type 1 fimbriae is mediated by the fimAICDHF
operon of serotype Typhimurium (3, 14, 23). A distinct fimbrial
type, termed thin curled fimbriae, was subsequently described
by electron microscopic observation of the surfaces of serotype
FIG. 3. (A) Bacteria recovered from feces of mice vaccinated either with GST (squares) or with a cocktail containing 11 GST-fimbrial fusion
proteins (circles) and then challenged with serotype Typhimurium. Data represent geometric means  standard errors. (B) Bacteria recovered
from organs 28 days after infection of mice vaccinated either with GST (control) or with a cocktail containing 11 GST-fimbrial fusion proteins
(cocktail). The circles represent data for individual animals.
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Typhimurium cells grown on agar plates (10). N-terminal se-
quencing of the major subunit of thin curled fimbriae, termed
AgfA (CsgA), identified this structure as being orthologous to
the thin aggregative fimbriae of S. enterica serotype Enteritidis
and the curly fimbriae of Escherichia coli (26). Although whole-
genome sequencing revealed the presence of 13 putative fim-
brial operons in serotype Typhimurium, type 1 fimbriae and
thin curled fimbriae are currently the only two fimbrial struc-
tures that have been visualized on the surface of this pathogen
by electron microscopy (15). We have recently shown by flow
cytometry with antisera against 11 major fimbrial subunits that
when serotype Typhimurium is cultured in LB broth, the only
fimbrial antigen detectable on its surface is FimA (11). Here
we extend this finding by showing that after growth under
various in vitro growth conditions (including LB broth), the
only fimbrial protein detected in serotype Typhimurium by
Western blotting was FimA. A transcriptional fusion to the pef
operon is induced when serotype Typhimurium is cultured in
LB broth buffered to pH 5.1 (19). An analysis of serotype
Typhimurium grown in LB broth buffered to pH 5.1 by flow
cytometry using rabbit anti-PefA antiserum and an anti-rabbit–
fluorescein isothiocyanate conjugate showed that only a small
fraction of cells (approximately 3%) have fluorescence above
background levels (11). This low level of PefA expression was
not detectable by the Western blot performed for this study.
Likewise, a flow cytometric analysis of serotype Typhimurium
for the expression of 11 fimbrial proteins upon growth in CFA
broth showed that a considerable fraction of cells (approxi-
mately 15%) express FimA, while only a small fraction of cells
(5%) show fluorescence above background levels when la-
beled with antisera specific for other fimbrial proteins (11).
Here we show that FimA is the only fimbrial protein detectable
by Western blotting in serotype Typhimurium grown in CFA
broth. Collectively, these data suggest that with the exception
of FimA and AgfA, fimbrial proteins are either not expressed
or are expressed at very low levels (i.e., below the limit of
detection of Western blotting) when serotype Typhimurium is
cultured under standard laboratory growth conditions.
Although it is currently not known which regulatory mech-
anisms prevent the in vitro expression of the majority of the 13
fimbrial operons identified by whole-genome sequencing, pre-
vious studies provided support for the idea that the expression
FIG. 4. Detection of fimbrial antigens and O antigen in the ceca of mice infected with serotype Typhimurium. Magnification, 400. The left
panels show the detection of the serotype Typhimurium O antigen by fluorescence microscopy (Alexa Fluor 594 [red fluorescence]). The middle
panels show the binding of anti-BcfA serum (A), anti-LpfA serum (B), or anti-StcA serum (C) to the same sections (Alexa Fluor 488 [green
fluorescence]). The right panels show overlays of red fluorescence (O antigen), green fluorescence (fimbrial proteins), and blue fluorescence
(Hoechst nuclear stain).
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of the encoded antigens is induced in vivo. Seroconversion to
LpfA is observed in mice upon infection with a serotype Ty-
phimurium aroA vaccine strain (20), while chickens infected
with S. enterica serotype Enteritidis seroconvert to PefA and
FimA (1, 30). Furthermore, the expression of BcfA, StbA,
SthA, LpfA, PefA, StdA, StcA, StiA, and StfA is detected by
flow cytometry 8 h after the infection of bovine ligated ileal
loops with serotype Typhimurium (11). Here we show that an
oral infection of mice with serotype Typhimurium resulted in
seroconversion to all 11 fimbrial proteins studied. Since the
serotype Typhimurium culture grown in LB broth and used to
inoculate mice expressed only FimA (as shown by Western
blotting), seroconversion suggested that the expression of
AgfA, BcfA, StbA, SthA, LpfA, PefA, StdA, StcA, StiA, and
StfA was induced in vivo during the course of the infection.
The detection of serotype Typhimurium expressing BcfA,
StcA, and LpfA in the ceca of infected mice by fluorescence
microscopy provided further support for the in vivo expression
of fimbrial antigens (Fig. 4).
Serotype Typhimurium infection resulted in higher antibody
titers against LPS than against individual fimbrial proteins.
Each individual animal only developed a response against a
subset of the 11 fimbrial proteins investigated. A possible ex-
planation for this observation may be the regulation of fimbrial
protein expression by phase variation. However, the phase-
variable expression of fimbrial genes has only been investigated
for the fim, lpf, and pef operons (19, 21, 27), and it is currently
not clear whether other fimbrial operons also alternate be-
tween phase-on and phase-off expression states. Alternatively,
the fact that different animals developed antibodies against
different subsets of fimbrial proteins may be due to genetic
differences between animals. In support of this idea, differ-
ences in the responses of individual animals were also observed
when mice were vaccinated with a cocktail of fimbrial proteins
(Fig. 2).
The immunization of mice with mixtures of GST-AgfA,
GST-BcfA, GST-StbA, GST-SthA, GST-LpfA, GST-PefA,
GST-StdA, GST-StcA, GST-StiA, and GST-StfA fusion pro-
teins resulted in serum Ig responses that were increased at
least fivefold compared to those in mice immunized with GST.
The only exception was GST-FimA, which did not elicit a
marked increase in serum Ig titer when injected into mice in
conjunction with other fimbrial fusion proteins. FimA was the
only protein whose expression could be detected by Western
blotting in the serotype Typhimurium culture used to challenge
mice immunized with fimbrial proteins. Thus, the fact that an
immune response against AgfA, BcfA, StbA, SthA, LpfA,
PefA, StdA, StcA, StiA, and StfA resulted in a significant
reduction of bacterial numbers shed with the feces further
corroborated the notion that these serotype Typhimurium an-
tigens are expressed during infection of mice.
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